According to a new market report published by Lucintel, the future of the drug screening market looks promising with opportunities in the workplace, criminal justice systems and law enforcement agencies, drug treatment centers, pain management centers, hospitals, and drug testing laboratories. The drug screening market is expected to grow with a CAGR of 10% from 2019 to 2024. The major drivers for this market are growing drug and alcohol consumption, enforcement of stringent laws mandating drug and alcohol testing, and presence of government funding in major markets.
To download report brochure, please go to https://www.lucintel.com/drug-screening-market.aspx and click "report brochure" tab from the menu.
In this market, analytical instruments, rapid testing devices, and drug screening service are used to screen the drug. Rapid testing devices segmented into urine testing devices and oral fluid testing devices where oral fluid testing device is expect to have highest CAGR during the forecast period.
Urine, breath, oral fluid, hair, other samples are the used to determine the drug screening. Oral fluid is the largest sample segment of the drug screening market.
North America will remain the largest region over the forecast period due to rising consumption of illicit drugs, availability of government funding to curb drug abuse, and the presence of laws supporting drug screening, and growing burden of accidents due to unsafe levels of alcohol consumption. large amount of drug abuse and adoption of drug screening devices in the region.
Alere, Thermo Fisher Scientific, Drägerwerk, Labcorp, Quest Diagnostics, Alfa Scientific Designs, Lifeloc, MPD, Orasure, Omega Laboratories, Premier Biotech, Psychemedics, Roche, Shimadzu, and Siemens Healthineers are among the major manufacturers of drug screening.
Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the drug screening market by product and service, sample type, end user, and region. Lucintel has prepared a comprehensive research report titled "Drug Screening Market 2019-2024: Trends, Forecast, and Opportunity Analysis". The Lucintel report serves as a catalyst for growth strategy as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes a forecast for the drug screening market by product and service, sample type, end user, and region as follows:
By Product and Service [$M shipment analysis for 2013 – 2024]:
Analytical Instruments
Rapid Testing Devices
Drug Screening Services
By Sample Type [$M shipment analysis for 2013 – 2024]:
Urine
Breath
Oral Fluid
Hair
Other Samples
By End User [$M shipment analysis for 2013 – 2024]:
Workplace
Criminal Justice Systems and Law Enforcement Agencies
Drug Treatment and Pain Management Centers
Hospitals
Others
By Region [$M shipment analysis for 2013 – 2024]:
North America
United States
Canada
Mexico
Europe
United Kingdom
Germany
France
Italy
Spain
Asia-Pacific
ROW
This 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link https://www.lucintel.com/drug-screening-market.aspx or helpdesk@lucintel.com.
About Lucintel
Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.